Medicare Enrolled

Dr. Michael Klebuc, M.D.

Vascular Surgery · Houston, TX
Mixed engagement
6560 FANNIN ST, Houston, TX 77030
7134416106
In practice since 2006 (19 years)
NPI: 1225067887 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Klebuc from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Klebuc? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Klebuc

Dr. Michael Klebuc is a vascular surgery in Houston, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Klebuc received a total of $203,830 from 21 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular surgery. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Klebuc is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $203,830 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$203,830
Total received (2018-2024)
Avg $29,119/year across 7 years
Top 2% in TX for vascular surgery
21
Companies
59
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$200,000 (98.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,830 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$680
2023
$1,197
2022
$651
2021
$302
2020
$255
2019
$200,417
2018
$329

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BAXTER HEALTHCARE
$200,000
Mentor Worldwide LLC
$692
ABBVIE INC.
$524
Allergan, Inc.
$442
Davol Inc.
$270
Allergan Inc.
$243
Medtronic, Inc.
$225
Alafair Biosciences, Inc.
$187
Vioptix Inc
$181
Integra LifeSciences Corporation
$147
AXOGEN
$140
Musculoskeletal Transplant Foundation Inc.
$135
Zimmer Biomet Holdings, Inc.
$115
DePuy Synthes Sales Inc.
$113
Sientra, Inc.
$108
Checkpoint Surgical, Inc
$107
Stryker Corporation
$107
Pacira Pharmaceuticals Incorporated
$37
Baxter Healthcare
$36
AbbVie Inc.
$18
Kerecis Limited
$4
Top 3 companies account for 98.7% of total payments
Associated products mentioned in payments ›
ALLODERM · AVANCE NERVE GRAFT · AxoGuard Nerve Connector · Checkpoint Stimulators · DALVANCE · DuraSorb Monofilament Mesh · Exparel · Kerecis Omega3 SurgiClose · MATRIXMANDIBLE · MENTOR MemoryGel Resterilizable Gel Sizer · MIDAS REX · MemoryGel Breast Implants · NATRELLE SALINE-FILLED BREAST IMPLANTS · No Related Product · PERCLOT · Phasix Mesh · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · T. Ox Oximeter · V-LOC 180 · VSP RECONSTRUCTION · VersaWrap · Walter
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for vascular surgery in TX.

Looking for a vascular surgery in Houston?
Compare vascular surgerys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse vascular surgerys nearby

Geographic Context

Vascular Surgerys within 10 mi
84
Per 100K population
1.8
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Klebuc is a vascular surgery, and high industry engagement (mixed engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Klebuc receive payments from pharmaceutical companies?
Yes. Dr. Klebuc received a total of $203,830 from 21 companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Klebuc) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →